Buys
Open market- Shares
- Avg price
- Total value
Holly B. Kordasiewicz - EVP, Chief Development Officer at IONIS PHARMACEUTICALS INC
Issuer-level insider activity
- Role
- EVP, Chief Development Officer
- Issuer ticker
- IONS on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Holly B. Kordasiewicz in IONIS PHARMACEUTICALS INC
Sells
Open market- Shares
- -64,987
- Avg price
- $73.55
- Total value
- -$4,779,736
Net
Past year- Shares
- -64,987
- Share %
- -100%
- Total value
- -$4,779,736
Reported holdings for Holly B. Kordasiewicz in IONIS PHARMACEUTICALS INC
Form 4 holding
EVP, Chief Development Officer
IONIS PHARMACEUTICALS INC
- Security class
- Common Stock
- Shares / value
- 22,458
- Estimated value
- $1,663,021
- Report date
- 12 Jun 2026
- Price
- $74.05
- Ownership
- Direct
Form 4 holding
EVP, Chief Development Officer
IONIS PHARMACEUTICALS INC
- Security class
- Restricted Stock Unit
- Shares / value
- 45,730
- Estimated value
- Report date
- 15 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
EVP, Chief Development Officer
IONIS PHARMACEUTICALS INC
- Security class
- Non-Qualified Stock Option (right to buy)
- Shares / value
- 0
- Estimated value
- Report date
- 12 Jun 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Holly B. Kordasiewicz in IONIS PHARMACEUTICALS INC
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.